Rare Cancers Australia Ltd (ABN 24 159 196 997) (RCA) endorses and supports the delivery of international best clinical practice including access to therapeutics and medicines by members of societies and professions, to benefit patient management.

The information in this portal with regard to Medicines Access Programs is the responsibility of and has been entered into by each participating Pharmaceutical Company. RCA (or any party associated with RCA and/or the development of this portal) does not warrant or represent that the information is accurate, current, free from errors or omissions.

The information and data in this portal are intended solely for Australian Health Practitioner Regulation Agency (AHPRA)-registered medical practitioners and pharmacists.

The use of the information and data contained in this portal is at the sole risk and based on the clinical discretion of qualified members of the AHPRA-registered healthcare professionals as noted above. Medical practitioners and pharmacists using the information and data are responsible for ensuring by independent verification, its accuracy, currency or completeness.

The information provided should not be regarded as a substitute for detailed expert advice on individual patients or clinical cases. RCA will accept no responsibility for any loss, claim or damage suffered or caused by any person acting or refraining from action as a result of any material in this portal.

Information presented in this portal is the copyright of RCA or the participating Pharmaceutical Companies. Apart from any use as permitted under the Copyright Act 1968 or as otherwise permitted under the Terms and Conditions, no part of this information may be reproduced without written permission.

Last Updated June 01, 2023.